Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer

Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer

The aim of the study was to assess the clinical prognostic value of serum cytokeratin 19 fragment (CYFRA21-1) and carcinoembryonic antigen (CEA) for non-small-cell lung cancer (NSCLC) patients. Literatures related to effects of serum CYFRA21-1 and CEA on the prognosis of lung cancer patients were re...

Full description

Bibliographic Details
Main Authors:	Zhang, Zhi-Hui, Han, Yun-Wei, Liang, Hui, Wang, Le-Min
Format:	Online
Language:	English
Published:	John Wiley & Sons, Ltd 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673989/

Similar Items

High Serum CEA and CYFRA21-1 Levels after a Two-Cycle Adjuvant Chemotherapy for NSCLC: Possible Poor Prognostic Factors
by: Lin, Xue-feng, et al.
Published: (2012)

Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples
by: Thomas, D S, et al.
Published: (2015)

Evaluation of serum cyfra21 in patients with pleural effusion
by: Azimi, Q, et al.
Published: (2012)

Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma
by: Yuan, Chuanshu, et al.
Published: (2016)

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study
by: Ono, Akira, et al.
Published: (2013)

Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients
by: Romero-Ventosa, Elena Yaiza, et al.
Published: (2015)

Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study
by: Xianfeng Li, et al.
Published: (2017-05-01)

Clinical significance of serum CYFRA 21-1 in gastric cancer.
by: Nakata, B., et al.
Published: (1996)

CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases.
by: Tempfer, C., et al.
Published: (1998)

Increases in Serum CYFRA21-1 Concentration during Successful Treatment with Crizotinib
by: Kanaji, Nobuhiro, et al.
Published: (2014)

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.
by: van der Gaast, A., et al.
Published: (1994)

Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer
by: PANG, LI, et al.
Published: (2013)

Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer.
by: Niklinski, J., et al.
Published: (1996)

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy
by: Mathieu Gauthé, et al.
Published: (2018-04-01)

A Comparison of Serum CYFRA 21-1 and SCC Ag in the Diagnosis of Squamous Cell Lung Carcinoma
by: Kim, Young-Chul, et al.
Published: (1996)

Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma
by: Hsu, Yin-Ping, et al.
Published: (2015)

CYFRA 21-1 in urine: a diagnostic marker for endometriosis?
by: Gjavotchanoff, Risto
Published: (2015)

Serum level of DKK-1 and its prognostic potential in non–small cell lung cancer
by: Dong, Liang-liang, et al.
Published: (2014)

The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer
by: Xu Liu, et al.
Published: (2016-01-01)

Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer
by: Boeck, S, et al.
Published: (2013)

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
by: Takada, M., et al.
Published: (1995)

SPARC expression and prognostic value in non-small cell lung cancer
by: Huang, Yan, et al.
Published: (2012)

Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma
by: Cao, Xun, et al.
Published: (2012)

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer
by: Shao, Yingbo, et al.
Published: (2015)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
by: Wang, Wei, et al.
Published: (2016)

The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.
by: Lundin, J., et al.
Published: (1994)

Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma.
by: Staab, H. J., et al.
Published: (1981)

Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer.
by: Staab, H. J., et al.
Published: (1982)

Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients
by: Dai, Danian, et al.
Published: (2016)

Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations
by: Yuan Gao, et al.
Published: (2017-07-01)

The relationship between glasgow prognostic score and serum tumor markers in patients with advanced non-small cell lung cancer
by: Jiang, Ai-Gui, et al.
Published: (2015)

Prognostic value and clinicopathological significance of epithelial cadherin expression in non-small cell lung cancer
by: Qiu, Zhi-Xin, et al.
Published: (2015)

Prognostic value of genomic damage in non-small-cell lung cancer.
by: de Juan, C., et al.
Published: (1998)

Prognostic value of LIPC in non-small cell lung carcinoma
by: Alifano, Marco, et al.
Published: (2013)

The diagnostic and prognostic value of serum human kallikrein-related peptidases 11 in non-small cell lung cancer
by: Xu, Chun-Hua, et al.
Published: (2014)

Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer
by: Korbakis, D, et al.
Published: (2015)

Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer
by: Jiang, Richeng, et al.
Published: (2016)

The Prognostic Value of Phosphorylated AKT Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
by: Qiu, Zhi-Xin, et al.
Published: (2013)

Heteroplasmy of mutant mitochondrial DNA A10398G and analysis of its prognostic value in non-small cell lung cancer
by: Qi, Yuexiao, et al.
Published: (2016)

Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
by: Salama, G., et al.
Published: (1998)